PTKFY Kalbe Farma Tbk PT ADR

USD 21.05 0.00 0
Icon

Kalbe Farma Tbk PT ADR (PTKFY) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 21.05

0.00 (0.00)%

USD 6.73B

N/A

N/A

N/A

Icon

PTKFY

Kalbe Farma Tbk PT ADR (USD)
COMMON STOCK | OTC
USD 21.05
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 6.73B

N/A

USD 21.05

Kalbe Farma Tbk PT ADR (PTKFY) Stock Forecast

N/A

Based on the Kalbe Farma Tbk PT ADR stock forecast from 0 analysts, the average analyst target price for Kalbe Farma Tbk PT ADR is not available over the next 12 months. Kalbe Farma Tbk PT ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Kalbe Farma Tbk PT ADR is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Kalbe Farma Tbk PT ADR’s stock price was USD 21.05. Kalbe Farma Tbk PT ADR’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -29.29% over the last year.

No recent analyst target price found for Kalbe Farma Tbk PT ADR
No recent average analyst rating found for Kalbe Farma Tbk PT ADR

Company Overview Kalbe Farma Tbk PT ADR

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals and Distribution; and Logistic. The company pr...Read More

https://www.kalbe.co.id

Gedung KALBE, Jakarta, Indonesia, 10510

13,165

December

USD

USA

Adjusted Closing Price for Kalbe Farma Tbk PT ADR (PTKFY)

Loading...

Unadjusted Closing Price for Kalbe Farma Tbk PT ADR (PTKFY)

Loading...

Share Trading Volume for Kalbe Farma Tbk PT ADR Shares

Loading...

Compare Performance of Kalbe Farma Tbk PT ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PTKFY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Kalbe Farma Tbk PT ADR (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHHVF
Roche Holding AG Participation 0.00 (0.00%) USD227.02B 17.92 12.62

ETFs Containing PTKFY

Symbol Name PTKFY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Kalbe Farma Tbk PT ADR (PTKFY) Stock

Stock Target Advisor's fundamental analysis for Kalbe Farma Tbk PT ADR's stock is Neutral.

PTKFY stock's dividend yield is 1.75%. Our analysis grades PTKFY stock's dividend yield at F. This means that PTKFY stock's dividend yield is above 14% of the stocks in the Drug Manufacturers - General sector in the OTC exchange. Based on this PTKFY may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on PTKFY's stock to indicate what its average analyst target is.

PTKFY stock's Price/Earning ratio is 30.00. Our analysis grades PTKFY stock's Price / Earning ratio at F. This means that PTKFY stock's Price/Earning ratio is above 71% of the stocks in the Drug Manufacturers - General sector in the OTC exchange. Based on this PTKFY may be a overvalued for its sector.

The last closing price of PTKFY's stock was USD 21.05.

The most recent market capitalization for PTKFY is USD 6.73B.

Unfortunately we do not have enough analyst data on PTKFY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Kalbe Farma Tbk PT ADR's stock.

As per our most recent records Kalbe Farma Tbk PT ADR has 13,165 Employees.

Kalbe Farma Tbk PT ADR's registered address is Gedung KALBE, Jakarta, Indonesia, 10510. You can get more information about it from Kalbe Farma Tbk PT ADR's website at https://www.kalbe.co.id.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...